• Agenda
    • Get Involved
    • Programs
    • In-Person Breakouts
    • Short Courses
    • Plenary Keynotes
    • Speaker Biographies
    • Training Seminars
    • Attendees
    • Search the Agenda
    • Networking
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors - Floorplan
    • Re-sign Floorplan
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
    • Best of Show Awards
  • Media
    • Media Partners
    • Downloads
    • Media Gallery
  • Travel
  • Posters
    • Poster Information
    • Poster Titles
  • Register
    • Individual Pricing
    • Group Pricing
    • On Demand Pricing
Discovery on Target 2024

2024 Media Partners

Official Publications

  • Bio-IT World
  • Diagnostic World News

Sponsoring Publications

  • American_Pharmaceutical_Review
    •  
  •  de-gruyter
  • Pharmaceutical_Outsourcing
  • PharmaVoice

Lead Media Partners

  • Biocompare
  • labcompare

Media Partners

  • BioPharma Asia Logo Image
  • Dr GPCR Logo

Web Sponsors

  • Big3Bio
  • Bioseeker-1st-Oncology
  • Genetic-Engineering-Biotech-News
    •  
  • pharmaceutics

 


Outlook YouTube LinkedIn Twitter
#BostonDOT24
2024 Final Agenda Download
Register Early for Maximum Savings
Stay up to Date on our 2023 Program
2024 Programs
Plan your Week

Conference Programs

September 30

Strategies for Targeting Kinases Covalent Chemistries and Induced Proximity NEW Emerging Immune Modulation Strategies Synthetic Biology for Drug Discovery and Therapy NEW

October 1-2

Degraders and Molecular Glues – Part 1 Lead Generation Strategies Small Molecules for Cancer Targets Antibodies Against Membrane Protein Targets Small Molecules Targeting RNA AI/ML-Enabled Drug Discovery – Part 1 Physiologically Relevant Translational Models GPCR Pharmacodynamics: Kinetics, Allosterism, and Biased Agonism in Pharma Discovery NEW

October 2-3

Degraders and Molecular Glues – Part 2 Target Identification Strategies GPCR-Based Drug Discovery Cancer Antibodies Targeting Transcription Factors AI/ML-Enabled Drug Discovery – Part 2 Drug Exposure at the Target: The Role of ADME and Pharmacokinetics NEW
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers

Request Information

Privacy Policy